MedPath
NMPA Approval

Adalimumab Solution for Injection

国药准字S20200026

December 2, 2020

Drug Information

阿达木单抗注射液

汉达远

汉达远

注射剂

40mg(0.8ml)/瓶

生物制品

December 2, 2020

Company Information

Applicant Company

上海市徐汇区宜山路1289号1幢(D楼)全幢

Manufacturing Company

上海市徐汇区宜山路1289号1幢(D楼)全幢

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿达木单抗注射液 - NMPA 批准文号 | MedPath